CAR, chimeric antigen receptor, vasculature, antibody
Dr. St. Croix’s laboratory at the Mouse Cancer Genetics Program (MCGP), National Cancer Institute, USA has an open postdoctoral position. We seek a highly motivated, creative and bright individual to participate in a collaborative project that involves the targeting of tumor-associated stroma using T-cells engineered to express chimeric antigen receptors (CARs). The laboratory focuses on the characterization and exploitation of molecules associated with tumor angiogenesis. The successful candidate would be involved in developing, producing and characterizing new therapeutic antibodies and CARs that recognize cancer cells or its associated stroma, and preclinical testing of these agents using mouse tumor models. The tumor angiogenesis lab is located at the National Cancer Institute in Frederick with access to state-of-the-art facilities for antibody engineering, genomic analysis, pathology, and small animal imaging, among others.
Detailed information about Dr. St. Croix’s research and publications can be accessed at https://ccr.cancer.gov/Mouse-Cancer-Genetics-Program/brad-st-croix.
Candidates are expected to have completed, or be completing, a Ph.D. or M.D./Ph.D. in biomedical research with a strong publication record and expertise in molecular and cell biological techniques. Motivated candidates who are interested in innovative, high-impact research are encouraged to apply. A background in molecular biology, cancer biology or immunotherapy is preferred. Experience with chimeric antigen receptors (CARs) is a big plus.
Please send applications by e-mail to: firstname.lastname@example.org
Each application should consist of a cover letter describing your research experience and interests, curriculum vitae, bibliography, and contact information of three references (inclusion of your current supervisor is preferred).
HHS, NIH, and NCI are Equal Opportunity Employers